Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1284 +0.0002 (+0.16%)
Official Closing Price Updated: 8:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zomedica: After a Wild Winter, It’s Back to Business
While ZOM stock has been highly volatile, the business is progressing. The Truforma platform has launched and we'll start seeing revenue figures soon. 
Via InvestorPlace
Investor Impatience Will Send Zomedica Stock Back Below a Dollar
Zomedica may be worth a gamble at some point, but for now you can expect ZOM stock to continue falling well below $1 per share. 
Via InvestorPlace
Why Zomedica Is a Great Speculative Play Right Now
ZOM stock makes as much sense as it ever has right now. Truforma's best days are in front of it which is also true of Zomedica shares. 
Via InvestorPlace
Sales Model Shift Should Provide a Long-Term Boost for Zomedica
ZOM stock has pulled back sharply from its peak price, but Zomedica has an opportunity as it seeks to expand its market presence. 
Via InvestorPlace
Exposures COVID-19
Zomedica Stock Is Very Attractive Here As Its New Product Launch Takes Off
ZOM stock is very attractive today, currently well below its target value of $1.63 and assuming it takes 10% of the pet diagnostic market. 
Via InvestorPlace
3 Popular Reddit Stocks That Are Melting Down
Two months ago, the Reddit traders and day trading community thought investing was easy. Everything was going up, but things sure have changed.... 
Via Benzinga
3 Robinhood Stocks That Could Be Due For A Further Sell-Off
Successful trading is hard. Robinhood traders are learning a tough lesson as man... 
Via Benzinga
Why Zomedica Stock Plunged Today
Initial sales of a key product may be lower than investors were hoping for. 
Via The Motley Fool
Why Zomedica Stock is a Pure Gamble Right Now
ZOM stock double peaked last month before falling sharply, as investors await for the Truforma launch to pay off handsomely. 
Via InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... 
Via Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) shares rose 29.1% to $1.20 in pre-market trading. RiceBran Technologies is scheduled to host a conference call on April 28th to... 
Via Benzinga
GameStop, AMC, Penny And Crypto Stocks: Top Q1 Trends For Millennials And Gen Z
The increase in retail investors has put heavy emphasis on “meme stocks” that go viral across ... 
Via Benzinga
44 Biggest Movers From Yesterday
Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Zomedica Stock Is a Big-Time Speculative Buy
Zomedica announced April 15 that it would move to direct sales. ZOM stock dropped on the news. Below $1, it’s a speculative buy. 
Via InvestorPlace
If You Invested $1,000 In Zomedica Stock 1 Year Ago, Here's How Much You'd Have Now
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 48.7... 
Via Benzinga
Topics Stocks
Exposures US Equities
30 Stocks Moving In Thursday's Mid-Day Session
Gainers Teradata Corporation (NYSE: TDC) shares jumped 28.6% to $51.29 after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE: SEAC) gained 19.6... 
Via Benzinga
ZOM Stock: What Zomedica Investors Are Saying as the Pet Pharma Play Rallies
Zomedica (ZOM) stock is taking off on Thursday despite a lack of news concerning the maker of medical devices for veterinarians. 
Via InvestorPlace
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
Despite Recent Progress, Zomedica Has to Prove Its Value
Despite releasing Truforma ahead of schedule, Zomedica still has to overcome tough challenges facing the product. ZOM stock isn't a buy yet. 
Via InvestorPlace
42 Biggest Movers From Yesterday
Gainers Esports Technologies, Inc. (NASDAQ: EBET) shares jumped 507% to settle at $36.42 on Thursday. agilon health, inc. (NYSE: AGL) gained 34.8% to close at $31.00 after the... 
Via Benzinga
30 Stocks Moving In Thursday's Mid-Day Session
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 58.2% to $13.16 after gaining 14% on Wednesday. The company's 13D filing recently showed that Modell'... 
Via Benzinga
The Party’s Over for Zomedica Stock, So Stay Away
After falling back to $1 per share, expect headline-making "meme stock" ZOM stock to give up even more of its recent gains. 
Via InvestorPlace
Zomedica’s Price Has Changed but So Has the Narrative
With the market speaking loud and clear on ZOM stock, you don’t want to rush into this cheapened investment. 
Via InvestorPlace
22 Stocks Moving in Thursday's Pre-Market Session
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) rose 25.1% to $0.6485 in pre-market trading. Bit Digital, Inc. (NASDAQ: BTBT) rose 15.1% to $16.40 in pre-market trading after... 
Via Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers Galectin Therapeutics Inc. (NASDAQ: GALT) rose 37.6% to $2.98 in pre-market trading after the company said a paper published in the peer-reviewed Journal for... 
Via Benzinga
Should You Buy Zomedica in April?
The stock has been falling sharply in the past month. 
Via The Motley Fool
Zomedica Really Only Has Its Penny Status Keeping It Interesting
The past year has been great for pet-related stocks, and ZOM stock is as much a perfect example as it is a cautionary tale. 
Via InvestorPlace
Zomedica Stock Pullback Opens Door for Investors To Take a Small Position
Has ZOM stock bottomed or does it have further to fall? Investors who are interested in buying stock of animal health company Zomedica may want to pull the trigger with the share price down 47% since... 
Via InvestorPlace
You Don’t Want to Be the Last to Know What Zomedica Stock Is Realy Worth
The retirement of preferred stock seems like a clear win for Zomedica and ZOM stock. But the deal raises a key question as well. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Do Not Bet on Zomedica… At Least Not Yet
The early launch of Zomedica's Truforma does not guarantee commercial success. Before you bet on ZOM stock, the company needs to prove itself. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.